Skip to main content
SpringerLink
Log in

Medikamente zur Behandlung von sexuellen Funktionsstörungen

  • Chapter
  • First Online:
Kompendium der Psychiatrischen Pharmakotherapie

  • 7963 Accesses

Zusammenfassung

Indikationen, Wirkungsweise, Nebenwirkungen und Risiken, Kontraindikationen und Interaktionen werden für die Medikamente zur Behandlung von sexuellen Funktionsstörungen im allgemeinen Teil und dann für jedes Arzneimittel spezifisch im Präparateteil beschrieben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Achilli C, Pundir J, Ramanathan P, Sabatini L et al (2017) Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. Fertil Steril 107(2):475–482

    Article  CAS  Google Scholar 

  • Algeffari M, Jayasena CN, MacKeith P et al (2018) Testosterone therapy for sexual dysfunction in men with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabet Med 35(2):195–202

    Article  CAS  Google Scholar 

  • Bala A, Nguyen HMT, Hellstrom WJG (2018) Post-SSRI sexual dysfunction: a literature review. Sex Med Rev 6(1):29–34

    Article  Google Scholar 

  • Barton DL, Sloan JA, Shuster LT et al (2018) Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer 26(2):643–650

    Article  Google Scholar 

  • Chokka PR, Hankey JR (2018) Assessment and management of sexual dysfunction in the context of depression. Ther Adv Psychopharmacol 8(1):13–23

    Article  Google Scholar 

  • Clayton AH, Kingsberg SA, Goldstein I (2018) Evaluation and management of hypoactive sexual desire disorder. Sex Med 6(2):59–74

    Article  Google Scholar 

  • Corona G, Rastrelli G, Burri A et al (2016a) The safety and efficacy of Avanafil, a new 2(nd) generation PDE5i: comprehensive review and meta-analysis. Expert Opin Drug Saf 15(2):237–247

    Article  CAS  Google Scholar 

  • Corona G, Rastrelli G, Burri A et al (2016b) First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis. Andrology 4(6):1002–1009

    Article  CAS  Google Scholar 

  • Corona G, Rastrelli G, Morgentaler A et al (2017) Meta-analysis of results of testosterone therapy on sexual function based on International Index of Erectile Function Scores. Eur Urol 72(6):1000–1011

    Article  CAS  Google Scholar 

  • Fujioi J, Iwamoto K, Banno M et al (2017) Effect of adjunctive aripiprazole on sexual dysfunction in schizophrenia: a preliminary open-label study. Pharmacopsychiatry 50(2):74–78

    CAS  PubMed  Google Scholar 

  • Gacci M, Andersson KE, Chapple C et al (2016) Latest evidence of the use of phosphodiesterase 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 70(1):124–133

    Article  CAS  Google Scholar 

  • Gao L, Yang L, Qian S et al (2016) Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction. Int J Gynaecol Obstet 133(2):139–145

    Article  CAS  Google Scholar 

  • Giatti S, Diviccaro S, Panzica G, Melcangi RC (2018) Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? Endocrine 61(2):180–193

    Article  CAS  Google Scholar 

  • Gong B, Ma M, Xie W et al (2017) Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Int Urol Nephrol 49(10):1731–1740

    Article  CAS  Google Scholar 

  • Healy D, Le Noury J, Mangin D (2018) Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. Int J Risk Saf Med 29(3–4):125–134

    Article  Google Scholar 

  • Hong JH, Kwon YS, Kim IY (2017) Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors. Expert Opin Drug Metab Toxicol 13(2):183–192

    Article  CAS  Google Scholar 

  • Jaspers L, Feys F, Bramer WM et al (2016) Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis. JAMA Intern Med 176(4):453–462

    Article  Google Scholar 

  • Kingsberg SA, Clayton AH, Portman D et al (2019) Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet Gynecol 134(5):899–908

    Article  CAS  Google Scholar 

  • Montejo AL, Montejo L, Baldwin DS (2018) The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry 17(1):3–11

    Article  Google Scholar 

  • La Torre A, Giupponi G, Duffy DM et al (2015) Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs. Pharmacopsychiatry 48:1–6

    PubMed  Google Scholar 

  • Zhang D, Cheng Y, Wu K et al (2019) Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis. BMC Urol 19(1):2

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Berlin, Deutschland

    Prof. Dr. med. Dr. rer. nat. Matthias J. Müller

  2. Mainz, Deutschland

    Otto Benkert

Authors
  1. Prof. Dr. med. Dr. rer. nat. Matthias J. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Otto Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Otto Benkert .

Editor information

Editors and Affiliations

  1. ehemals Universitäts-Klinikum Mainz, Mainz, Germany

    Otto Benkert

  2. Klinik für Psychiatrie und Psychotherapie, ehemals Universitäts-Klinikum München Campus Innenstadt, München, Germany

    Hanns Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Müller, M.J., Benkert, O. (2021). Medikamente zur Behandlung von sexuellen Funktionsstörungen. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61753-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-61753-3_8

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-61752-6

  • Online ISBN: 978-3-662-61753-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation